HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Peter R Seevinck Selected Research
Peter R Seevinck Research Topics
Disease
9
Neoplasms (Cancer)
09/2019 - 10/2010
4
Prostatic Neoplasms (Prostate Cancer)
06/2018 - 10/2017
3
Hip Dislocation
01/2022 - 01/2020
1
Developmental Dysplasia of the Hip
01/2022
1
Osteoarthritis
01/2022
1
Congenital Hip Dislocation
01/2020
1
Head and Neck Neoplasms (Head and Neck Cancer)
09/2019
1
Brain Neoplasms (Brain Tumor)
11/2018
1
Rectal Neoplasms (Rectal Cancer)
07/2018
1
Kidney Neoplasms (Kidney Cancer)
01/2013
Drug/Important Bio-Agent (IBA)
3
acetyl acetonate (acetylacetonate)
IBA
03/2013 - 10/2010
2
Holmium-166
IBA
03/2013 - 01/2013
2
Holmium
IBA
01/2013 - 10/2010
1
Titanium
IBA
01/2022
1
Solutions
IBA
07/2018
1
Gold
IBA
06/2018
1
Protons (Proton)
IBA
11/2017
1
Capecitabine (Xeloda)
FDA Link
11/2015
Therapy/Procedure
6
Radiotherapy
09/2019 - 10/2017
2
Osteotomy
01/2022 - 01/2020
2
Therapeutic Embolization
03/2015 - 01/2013
2
Microspheres (Microsphere)
03/2013 - 01/2013
1
Salvage Therapy
01/2022
1
Hip Replacement Arthroplasty (Total Hip Replacement)
01/2022
1
Arthroplasty
01/2020
1
Image-Guided Radiotherapy
06/2018
1
Brachytherapy
10/2017
1
Palliative Care (Palliative Therapy)
11/2015
1
Therapeutics
01/2013
1
Injections
10/2010